Search Login Register

eptifibatide (Integrilin) Summary

Description: used in clinical studies as a platelet glycoprotein IIB/IIIA antagonist

Also Known As: Integrilin; Cor brand of eptifibatide; Essex brand of eptifibatide; GlaxoSmithKline UK brand of eptifibatide; Integrelin Show All >>

Networked: 439 relevant articles (52 outcomes, 158 trials/studies) for this Drug

Key Diseases for which eptifibatide is Relevant

  1. Acute Coronary Syndrome : 23 outcomes 58 studies in 138 results
  2. Myocardial Infarction : 15 outcomes 50 studies in 128 results
  3. Unstable Angina : 9 outcomes 51 studies in 86 results
  4. Hemorrhage : 6 outcomes 23 studies in 92 results
  5. Ischemia : 5 outcomes 6 studies in 13 results
Show All >>

Drugs Related to eptifibatide

  1. eptifibatide (Integrilin)
  2. Glycoproteins (Glycoprotein)
  3. tirofiban (Aggrastat)
  4. Enoxaparin (Lovenox)
  5. Heparin (Liquaemin)
  6. abciximab (ReoPro)
  7. Platelet Membrane Glycoprotein IIb
  8. Aspirin (Acetylsalicylic Acid)
  9. clopidogrel (Plavix)
  10. tenecteplase
Show All >>

Therapies Related to eptifibatide

  1. Stents
  2. Drug-Eluting Stents
  3. Coronary Artery Bypass (Coronary Artery Bypass Surgery)
  4. Thrombolytic Therapy
  5. Resuscitation
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.